A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers

Introduction: Several recent studies pointed out that chromodomain-helicase-DNA-binding protein 1-like (CHD1L) is a putative oncogene in many human tumors. However, up to date, there is no pan-cancer analysis performed to study the different aspects of this gene expression and behavior in tumor tiss...

Повний опис

Бібліографічні деталі
Автори: Mohamed A. Soltan, Muhammad Alaa Eldeen, Refaat A. Eid, Najiah M. Alyamani, Leena S. Alqahtani, Sarah Albogami, Ibrahim Jafri, Moon Nyeo Park, Ghadi Alsharif, Eman Fayad, Gamal Mohamed, Rihab Osman, Bonglee Kim, Mohamed Samir A. Zaki
Формат: Стаття
Мова:English
Опубліковано: Frontiers Media S.A. 2023-03-01
Серія:Frontiers in Molecular Biosciences
Предмети:
CHD1L
pan-cancer
differential expression
prognosis
tumor immunotherapy
biomarker
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1017148/full

Інтернет

https://www.frontiersin.org/articles/10.3389/fmolb.2023.1017148/full

Схожі ресурси